表紙
市場調查報告書

脊椎移植、手術用設備的全球市場 - 機會分析與產業預測:2020年∼2027年

Spinal Implant and Devices Market by Type and Surgery : Global Opportunity Analysis and Industry Forecast 2020-2027

出版商 Allied Market Research 商品編碼 955640
出版日期 內容資訊 英文 268 Pages
商品交期: 2-3個工作天內
價格
脊椎移植、手術用設備的全球市場 - 機會分析與產業預測:2020年∼2027年 Spinal Implant and Devices Market by Type and Surgery : Global Opportunity Analysis and Industry Forecast 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 268 Pages
簡介

全球脊椎移植、手術用設備市場,從2019年的113億5659萬美元,預計到2027年達到150億5407萬美元,2020年∼2027年以5.7%的年複合成長率成長。市場由於微創的脊椎手術的轉移受到促進。一般認為起因於老年人口的增加和久坐的生活方式的脊椎疾病的發生率的上升,帶動市場成長。還有脊椎手術的進步和新產品的銷售,更加推動市場。

本報告提供全球脊椎移植、手術用設備市場相關調查分析,市場概要,市場規模與預測,各分類市場分析,各地區市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 主要企業的定位
  • 市場佔有率分析
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 影響分析
  • 波特的五力分析
  • 臨床試驗
  • 政府的法規
  • COVID-19對脊椎移植、手術用設備市場的影響分析

第4章 脊椎移植、手術用設備市場:各產品

  • 概要
  • 脊椎固定器
  • 脊椎骨刺激器
  • 保存活動性設備
  • 脊椎壓迫性骨折 (VCF) 治療設備
  • 脊椎用生技藥品

第5章 脊椎移植、手術用設備市場:各手術

  • 概要
  • 開放性手術
  • 微創手術

第6章 脊椎移植、手術用設備市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • Alphatec Holdings, Inc.
  • B. Braun Melsungen AG
  • Exactech, Inc.
  • Johnson & Johnson (DePuy Synthes)
  • Globus Medical, Inc.
  • Medtronic plc.
  • Nuvasive, Inc.
  • Orthofix International N.V.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
目錄
Product Code: A01295

Title:
Spinal Implant and Devices Market by Type (Spinal Fusion Implants, Spinal Bone Stimulators, Vertebral Compression Fracture (VCF) Devices, Motion Preservation Devices, and Spine Biologics) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery): Global Opportunity Analysis and Industry Forecast 2020-2027.

The global spinal implants and devices market was valued at $11,356.59 million in 2019 and is projected to reach $15,054.07 million by 2027 at a CAGR of 5.7% from 2020 to 2027.

Spine-related disorders and deformities are treated using spinal implants and devices. Disorders such as spinal stenosis and lumbar degenerative spondylolisthesis are caused from degeneration of intervertebral disc, deformity, tumors, and trauma. In addition, implant systems utilize specially designed spinal instrumentation such as plates, rods, and screws, which help to facilitate fusion, correct deformities, and stabilize and strengthen the spine. Most spinal implants are made of metals such as titanium and are available in different shapes and sizes to be used in patients of all ages.

The market is driven by shift toward minimally invasive spine procedure. Growth in elderly population and rise in incidences of spinal disorders attributed to sedentary lifestyle is expected to drive the market growth. In addition, advancements in spine surgeries and new product launches further fuel the market. However, stringent regulatory approval procedures, present pandemic situation and unfavorable reimbursement scenario are expected to hamper growth of the spinal implant and devices market. Moreover, emerging markets are expected to drive demand for spinal implants and devices and advancements in augmented and virtual reality, endoscopic surgery and 3D printed implants for minimally invasive surgery are also expected to fuel the market growth.

The report segments the spinal implants and devices market on the basis of type, surgery, and region. According to the product type, it is segmented into spinal fusion implants, motion preservation devices, vertebral compression fracture (VCF) devices, spine bone stimulators and spine biologics. By surgery type, it is bifurcated into open spine surgery and minimally invasive spine surgery. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Over the past few years, key players have adopted product development such as product launches, approvals, and clinical trials as their key strategies. For instance, in September 2019, J&J launched a 3D Printed Implant Portfolio (CONDUIT Interbody Platform with EIT Cellular Titanium Technology) for spine surgery to expand comprehensive offering to treat degenerative spine disease. Moreover, in February 2019, Orthofix received US Food and Drug Administration (FDA) approval for M6-C artificial cervical disc (Orthofix Medical) for patients suffering from cervical disc degeneration. This artificial disc was developed by Spinal Kinetics.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global spinal implants and devices market with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict the market growth is provided.

Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.

Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Type

  • Spinal Fusion Implants
  • Thoracolumbar Devices
  • Anterior Lumbar Plates
  • Lumbar Plates
  • Pedicle Screw
  • Rods
  • Hooks
  • Wires & Cables
  • Crosslinks
  • Cervical Fixation Devices
  • Anterior Cervical Plates
  • Hook Fixation Systems
  • Plates & Screws
  • Clamps
  • Wires
  • Interbody Fusion Devices
  • Non-Bone Interbody Fusion Devices
  • Bone Interbody Fusion Devices
  • Vertebral Compression Fracture (VCF) Devices
  • Balloon Kyphoplasty Devices
  • Vertebroplasty Devices
  • Motion Preservation Devices
  • Dynamic Stabilization Devices
  • Interspinous Process Spacers
  • Pedicle Screw-Based Systems
  • Facet Replacement Products
  • Artificial Discs
  • Artificial Cervical Discs
  • Artificial Lumbar Discs
  • Annulus Repair Devices
  • Nuclear Disc Prostheses
  • Spine bone stimulators
  • Non-Invasive Spine Bone Stimulators
  • Pulsed Electromagnetic Field Device
  • Capacitive Coupling (CC) and Combined (Electro) Magnetic Field (CMF) Devices
  • Invasive Spine Bone Stimulators
  • Spine Biologics
  • Spinal Allografts
  • Machined Bones Allograft
  • Demineralized Bone Matrix
  • Bone Graft Substitutes
  • Bone Morphogenetic Proteins
  • Synthetic Bone Grafts
  • Cell-Based Matrix

By Surgery

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • List of key players profiled in the report
  • Alphatec Holdings, Inc.
  • B. Braun Melsungen AG
  • Exactech, Inc.
  • Johnson & Johnson (DePuy Synthes)
  • Globus Medical, Inc.
  • Medtronic plc
  • Nuvasive, Inc.
  • Orthofix International N.V.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • List of the other key players (not included in the report) includes Aesculap Implant Systems, Aspen Medical Products, Amedica Corp., Camber Spine Technologies, Paragon Medical, Inc., Norman Noble, Inc., Nutech, Titan Spine, Wenzel Spine, Inc., X-spine Systems, Inc., Tecomet, Inc., Marox Corporation, Axial Medical, Spine Wave, Inc., K2M, Inc., and Captiva Spine, LLC.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.KEY BENEFITS
  • 1.2.KEY MARKET SEGMENTS
  • 1.3.Key players
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top winning strategies
    • 3.2.2.Top investment pockets
  • 3.3.Top player positioning, 2019
  • 3.4.Market share analysis, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Growing elderly population
      • 3.5.1.2.Increasing prevalence of spinal disorders due to sedentary lifestyles
      • 3.5.1.3.Advancements in spine surgery
      • 3.5.1.4.Increase in demand for minimally invasive surgical procedures
    • 3.5.2.Restraints
      • 3.5.2.1.Stringent regulatory approval procedure
      • 3.5.2.2.Unfavorable reimbursement scenario
    • 3.5.3.Opportunities
      • 3.5.3.1.Emerging markets to drive the demand for spinal implants and devices
      • 3.5.3.2.Advancement in augmented & virtual reality, endoscopic surgery and 3D printed implants for minimally invasive spine surgery
    • 3.5.4.Impact analysis
  • 3.6.Porter's five forces analysis
    • 3.6.1.Bargaining power of buyers
    • 3.6.2.Bargaining power of suppliers
    • 3.6.3.Threat of substitutes
    • 3.6.4.Threat of new entrants
    • 3.6.5.Competitive rivalry
  • 3.7.Clinical trials
  • 3.8.Government regulations
  • 3.9.Impact analysis of the Covid -19 for spinal implant and devices market

CHAPTER 4:SPINAL IMPLANTS AND DEVICES MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Spinal Fusion Devices
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market share analysis, by country
    • 4.2.4.Thoracolumbar devices
      • 4.2.4.1.Market size and forecast
    • 4.2.5.Cervical Fixation Devices
      • 4.2.5.1.Market size and forecast
    • 4.2.6.Interbody Fusion Devices
      • 4.2.6.1.Market size and forecast
  • 4.3.Spine Bone Stimulators
    • 4.3.1.Key market trends and opportunity
    • 4.3.2.Market size and forecast
    • 4.3.3.Market share analysis, by country
    • 4.3.4.Non-invasive spine bone stimulators
      • 4.3.4.1.Market size and forecast
    • 4.3.5.Invasive spine bone stimulators
      • 4.3.5.1.Market size and forecast
  • 4.4.Motion Preservation Devices
    • 4.4.1.Key market trends and opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market share analysis, by country
    • 4.4.4.Dynamic stabilization systems
      • 4.4.4.1.Market size and forecast
    • 4.4.5.Artificial Discs
      • 4.4.5.1.Market size and forecast
    • 4.4.6.Annulus repair devices
      • 4.4.6.1.Market size and forecast
    • 4.4.7.Nucleus disc prosthesis device
      • 4.4.7.1.Market size and forecast
  • 4.5.Vertebral Compression Fracture Devices
    • 4.5.1.Key market trends and opportunity
    • 4.5.2.Market size and forecast
    • 4.5.3.Market share analysis, by country
    • 4.5.4.Balloon kyphoplasty devices
      • 4.5.4.1.Market size and forecast
    • 4.5.5.Vertebroplasty devices
      • 4.5.5.1.Market size and forecast
  • 4.6.Spine Biologics
    • 4.6.1.Key market trends and opportunities
    • 4.6.2.Market size and forecast
    • 4.6.3.Market share analysis, by country
    • 4.6.4.Spinal allografts
      • 4.6.4.1.Market size and forecast
    • 4.6.5.Bone graft substitutes
      • 4.6.5.1.Market size and forecast
    • 4.6.6.Cell based matrix
      • 4.6.6.1.Market size and forecast

CHAPTER 5:SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Open Spine Surgery
    • 5.2.1.Market size and forecast
    • 5.2.2.Market share analysis, by country
  • 5.3.Minimally Invasive Spine Surgery
    • 5.3.1.Market size and forecast
    • 5.3.2.Market share analysis, by country

CHAPTER 6:SPINAL IMPLANTS AND DEVICES MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.North America market size and forecast, by country
    • 6.2.3.North America market size and forecast, by Type
    • 6.2.4.North America market size and forecast, by Surgery
      • 6.2.4.1.U.S.
      • 6.2.4.1.1.U.S. market size and forecast, by Type
      • 6.2.4.1.2.U.S. market size and forecast, by Surgery
      • 6.2.4.2.Canada
      • 6.2.4.2.1.Canada market size and forecast, by Type
      • 6.2.4.2.2.Canada market size and forecast, by Surgery
      • 6.2.4.3.Mexico
      • 6.2.4.3.1.Mexico market size and forecast, by Type
      • 6.2.4.3.2.Mexico market size and forecast, by Surgery
  • 6.3.Europe
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast
    • 6.3.3.Europe market size and forecast, by Type
    • 6.3.4.Europe market size and forecast, by Surgery
      • 6.3.4.1.Germany
      • 6.3.4.1.1.Germany market size and forecast, by Type
      • 6.3.4.1.2.Germany market size and forecast, by Surgery
      • 6.3.4.2.UK
      • 6.3.4.2.1.UK market size and forecast, by Type
      • 6.3.4.2.2.UK market size and forecast, by Surgery
      • 6.3.4.3.France
      • 6.3.4.3.1.France market size and forecast, by Type
      • 6.3.4.3.2.France market size and forecast, by Surgery
      • 6.3.4.4.Italy
      • 6.3.4.4.1.Italy market size and forecast, by Type
      • 6.3.4.4.2.Italy market size and forecast, by Surgery
      • 6.3.4.5.Spain
      • 6.3.4.5.1.Spain market size and forecast, by Type
      • 6.3.4.5.2.Spain market size and forecast, by Surgery
      • 6.3.4.6.Rest of Europe
      • 6.3.4.6.1.Rest of Europe market size and forecast, by Type
      • 6.3.4.6.2.Rest of Europe market size and forecast, by Surgery
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Market size and forecast
    • 6.4.3.Asia-Pacific market size and forecast, by Type
    • 6.4.4.Asia-Pacific market size and forecast, by Surgery
      • 6.4.4.1.India
      • 6.4.4.1.1.India market size and forecast, by Type
      • 6.4.4.1.2.India market size and forecast, by Surgery
      • 6.4.4.2.China
      • 6.4.4.2.1.China market size and forecast, by Type
      • 6.4.4.2.2.China market size and forecast, by Surgery
      • 6.4.4.3.Japan
      • 6.4.4.3.1.Japan market size and forecast, by Type
      • 6.4.4.3.2.Japan market size and forecast, by Surgery
      • 6.4.4.4.Australia
      • 6.4.4.4.1.Australia market size and forecast, by Type
      • 6.4.4.4.2.Australia market size and forecast, by Surgery
      • 6.4.4.5.South Korea
      • 6.4.4.5.1.South Korea market size and forecast, by Type
      • 6.4.4.5.2.South Korea market size and forecast, by Surgery
      • 6.4.4.6.Rest of Asia-Pacific
      • 6.4.4.6.1.Rest of Asia-Pacific market size and forecast, by Type
      • 6.4.4.6.2.Rest of Asia-Pacific market size and forecast, by Surgery
  • 6.5.LAMEA
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.Market size and forecast
    • 6.5.3.LAMEA market size and forecast, by Type
    • 6.5.4.LAMEA market size and forecast, by Surgery
      • 6.5.4.1.Brazil
      • 6.5.4.1.1.Brazil market size and forecast, by Type
      • 6.5.4.1.2.Brazil market size and forecast, by Surgery
      • 6.5.4.2.Saudi Arabia
      • 6.5.4.2.1.Saudi Arabia market size and forecast, by Type
      • 6.5.4.2.2.Saudi Arabia market size and forecast, by Surgery
      • 6.5.4.3.South Africa
      • 6.5.4.3.1.South Africa market size and forecast, by Type
      • 6.5.4.3.2.South Africa market size and forecast, by Surgery
      • 6.5.4.4.Rest of LAMEA
      • 6.5.4.4.1.Rest of LAMEA market size and forecast, by Type
      • 6.5.4.4.2.Rest of LAMEA market size and forecast, by Surgery

CHAPTER 7:COMPANY PROFILES

  • 7.1.Alphatec Holdings, Inc.
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating Business Segment
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.B. Braun Melsungen AG
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
    • 7.2.5.Business performance
  • 7.3.Exactech, Inc.
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating Business Segments
    • 7.3.4.Product portfolio
  • 7.4.Johnson & Johnson (DePuy Synthes)
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
    • 7.4.6.Key strategic moves and developments
  • 7.5.Globus Medical, Inc.
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.1.Operating Business Segments
    • 7.5.2.Product portfolio
    • 7.5.3.Business performance
  • 7.6.Medtronic plc.
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
    • 7.6.6.Key strategic moves and developments
  • 7.7.Nuvasive, Inc.
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
    • 7.7.5.Business performance
    • 7.7.6.Key strategic moves and developments
  • 7.8.Orthofix International N.V.
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating Business Segments
    • 7.8.4.Product portfolio
    • 7.8.5.Business performance
    • 7.8.6.Key strategic moves and developments
  • 7.9.Stryker Corporation
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
    • 7.9.6.Key strategic moves and developments
  • 7.10.Zimmer Biomet Holdings, Inc.
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating Product Categories
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance
    • 7.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.CLINICAL TRIALS: SPINAL IMPLANT AND DEVICES MARKET, 2010-2020
  • TABLE 02.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY TYPE ($MILLION), 2019-2027
  • TABLE 03.GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 04.GLOBAL SPINAL FUSION DEVICES MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 05.GLOBAL THORACOLUMBAR FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 06.GLOBAL CERVICAL FIXATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 07.GLOBAL INTERBODY FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 08.GLOBAL SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 09.GLOBAL SPINE BONE STIMULATORS MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 10.GLOBAL NON-INVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 11.GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 12.GLOBAL MOTION PRESERVATION DEVICES MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 13.GLOBAL DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 14.GLOBAL ARTIFICIAL DISCS MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 15.GLOBAL VCF DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 16.GLOBAL VCF DEVICES MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 17.GLOBAL SPINE BIOLOGICS MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 18.GLOBAL SPINE BIOLOGICS MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 19.GLOBAL SPINAL ALLOGRAFT MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 20.GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE ($MILLION), 2019 - 2027
  • TABLE 21.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY TYPE ($MILLION), 2019-2027
  • TABLE 22.GLOBAL OPEN SPINE SURGERY MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 23.GLOBAL MINIMALLY INVASIVE SPINE SURGERY MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 24.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY REGION ($MILLION), 2019-2027
  • TABLE 25.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 26.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 27.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 28.U.S. SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 29.U.S. SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 30.CANADA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 31.CANADA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 33.MEXICO SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 34.EUROPE SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY, ($MILLION) 2019-2027
  • TABLE 35.EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 37.GERMANY SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 38.GERMANY SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 39.UK SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 40.UK SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 41.FRANCE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 42.FRANCE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 43.ITALY SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 44.ITALY SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 45.SPAIN SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 46.SPAIN SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 47.REST OF EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 48.REST OF EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 49.ASIA-PACIFIC SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY ($MILLION), 2019-2027
  • TABLE 50.ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 51.ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 52.INDIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 53.INDIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 54.CHINA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 55.CHINA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 56.JAPAN SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 57.JAPAN SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 58.AUSTRALIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 59.AUSTRALIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 60.SOUTH KOREA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 61.SOUTH KOREA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 62.REST OF ASIA- PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 63.REST OF ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 64.LAMEA SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY ($MILLION), 2019-2027
  • TABLE 65.LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 66.LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 67.BRAZIL SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 68.BRAZIL SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 69.SAUDI ARABIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 70.SAUDI ARABIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 71.SOUTH AFRICA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 72.SOUTH AFRICA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 73.REST OF LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 74.REST OF LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019-2027 ($MILLION)
  • TABLE 75.ALPHATEC: COMPANY SNAPSHOT
  • TABLE 76.ALPHATEC: OPERATING SEGMENT:
  • TABLE 77.ALPHATEC: PRODUCT PORTFOLIO
  • TABLE 78.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 79.B. BRAUN: BUSINESS SEGMENTS
  • TABLE 80.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 81.EXACTECH: COMPANY SNAPSHOT
  • TABLE 82.EXACTECH: BUSINESS SEGMENTS
  • TABLE 83.EXACTECH: PRODUCT PORTFOLIO
  • TABLE 84.J&J: COMPANY SNAPSHOT
  • TABLE 85.J&J: BUSINESS SEGMENTS
  • TABLE 86.J&J: PRODUCT PORTFOLIO
  • TABLE 87.GLOBUS MEDICAL: COMPANY SNAPSHOT
  • TABLE 88.GLOBUS MEDICAL.: OPERATING SEGMENTS
  • TABLE 89.GLOBUS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 90.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 91.MEDTRONIC: BUSINESS SEGMENTS
  • TABLE 92.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 93.NUVASIVE: COMPANY SNAPSHOT
  • TABLE 94.NUVASIVE: BUSINESS SEGMENTS
  • TABLE 95.NUVASIVE: PRODUCT PORTFOLIO
  • TABLE 96.ORTHOFIX: COMPANY SNAPSHOT
  • TABLE 97.ORTHOFIX: BUSINESS SEGMENTS
  • TABLE 98.ORTHOFIX: PRODUCT PORTFOLIO
  • TABLE 99.STRYKER: COMPANY SNAPSHOT
  • TABLE 100.STRYKER: BUSINESS SEGMENTS
  • TABLE 101.STRYKER: PRODUCT PORTFOLIO
  • TABLE 102.ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 103.ZIMMER BIOMET: BUSINESS SEGMENTS
  • TABLE 104.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.MARKET SEGMENTATION
  • FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
  • FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020* (%)
  • FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020* (%)
  • FIGURE 05.TOP INVESTMENT POCKETS
  • FIGURE 06.TOP PLAYER POSITIONING, 2019
  • FIGURE 07.MARKET SHARE ANALYSIS, 2019
  • FIGURE 08.BARGAINING POWER OF BUYERS, 2019
  • FIGURE 09.BARGAINING POWER OF SUPPLIERS
  • FIGURE 10.THREAT OF SUBSTITUTES
  • FIGURE 11.THREAT OF NEW ENTRANTS
  • FIGURE 12.COMPETITIVE RIVALRY
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS SPINAL FUSION IMPLANT, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 14.SPINAL IMPLANTS AND DEVICES MARKET FOR ANTERIOR LUMBAR PLATES ($MILLION), 2019-2027
  • FIGURE 15.SPINAL IMPLANTS AND DEVICES MARKET FOR LUMBAR PLATES ($MILLION), 2019-2027
  • FIGURE 16.SPINAL IMPLANTS AND DEVICES MARKET FOR PEDICLE SCREW($MILLION), 2019-2027
  • FIGURE 17.SPINAL IMPLANTS AND DEVICES MARKET FOR RODS($MILLION), 2019-2027
  • FIGURE 18.SPINAL IMPLANTS AND DEVICES MARKET FOR HOOKS ($MILLION), 2019-2027
  • FIGURE 19.SPINAL IMPLANTS AND DEVICES MARKET FOR WIRES AND CABLES ($MILLION), 2019-2027
  • FIGURE 20.SPINAL IMPLANTS AND DEVICES MARKET FOR CROSSLINKS ($MILLION) 2019-2027
  • FIGURE 21.SPINAL IMPLANTS AND DEVICES MARKET FOR ANTERIOR CERVICAL PLATES ($MILLION), 2019-2027
  • FIGURE 22.SPINAL IMPLANTS AND DEVICES MARKET FOR HOOK FIXATION SYSTEMS ($MILLION), 2019-2027
  • FIGURE 23.SPINAL IMPLANTS AND DEVICES MARKET FOR PLATES AND SCREWS ($MILLION), 2019-2027
  • FIGURE 24.SPINAL IMPLANTS AND DEVICES MARKET FOR CLAMPS ($MILLION), 2019-2027
  • FIGURE 25.SPINAL IMPLANTS AND DEVICES MARKET FOR WIRES ($MILLION), 2019-2027
  • FIGURE 26.SPINAL IMPLANTS AND DEVICES MARKET FOR NON-BONE INTERBODY FUSION ($MILLION), 2019-2027
  • FIGURE 27.SPINAL IMPLANTS AND DEVICES MARKET FOR BONE INTERBODY FUSION ($MILLION), 2019-2027
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF SPINAL BONE STIMULATOR, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 29.SPINAL IMPLANTS AND DEVICES MARKET, FOR PULSED ELECTROMAGNETIC FIELD DEVICE, 2019-2027 ($MILLION)
  • FIGURE 30.SPINAL IMPLANTS AND DEVICES MARKET FOR CC AND CMF DEVICES ($MILLION), 2019-2027
  • FIGURE 31.SPINAL IMPLANTS AND DEVICES MARKET FOR INVASIVE SPINE BONE STIMULATORS ($MILLION), 2019-2027
  • FIGURE 32.COMPARATIVE SHARE ANALYSIS OF MOTION PRESERVATION DEVICES, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 33.SPINAL IMPLANTS AND DEVICES MARKET FOR INTERSPINOUS PROCESS SPACERS ($MILLION), 2019-2027
  • FIGURE 34.SPINAL IMPLANTS AND DEVICES MARKET FOR PEDICLE-BASED DYNAMIC RODS ($MILLION), 2019-2027
  • FIGURE 35.SPINAL IMPLANTS AND DEVICES MARKET FOR FACET REPLACEMENT DEVICE ($MILLION), 2019-2027
  • FIGURE 36.SPINAL IMPLANTS AND DEVICES MARKET FOR ARTIFICIAL CERVICAL DISCS ($MILLION), 2019-2027
  • FIGURE 37.SPINAL IMPLANTS AND DEVICES MARKET FOR ARTIFICIAL LUMBAR DISCS ($MILLION), 2019-2027
  • FIGURE 38.SPINAL IMPLANTS AND DEVICES MARKET FOR ANNULUS REPAIR DEVICE ($MILLION), 2019-2027
  • FIGURE 39.SPINAL IMPLANTS AND DEVICES MARKET FOR NUCLEUS DISC PROSTHESIS DEVICE ($MILLION), 2019-2027
  • FIGURE 40.COMPARATIVE SHARE ANALYSIS OF VERTEBRAL COMPRESSION FRACTURE DEVICES, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 41.SPINAL IMPLANTS AND DEVICES MARKET FOR BALLOON KYPHOPLASTY DEVICE ($MILLION), 2019-2027
  • FIGURE 42.SPINAL IMPLANTS AND DEVICES MARKET FOR VERTEBROPLASTY DEVICE ($MILLION), 2019-2027
  • FIGURE 43.COMPARATIVE SHARE ANALYSIS OF SPINE BIOLOGICS, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 44.SPINAL IMPLANTS AND DEVICES MARKET FOR MACHINED ALLOGRAFTS ($MILLION), 2019-2027
  • FIGURE 45.SPINAL IMPLANTS AND DEVICES MARKET FOR DEMINERALIZED BONE MATRIX ($MILLION), 2019-2027
  • FIGURE 46.SPINAL IMPLANTS AND DEVICES MARKET FOR BMP ($MILLION), 2019-2027
  • FIGURE 47.SPINAL IMPLANTS AND DEVICES MARKET FOR SYNTHETIC BONE GRAFTS ($MILLION), 2019-2027
  • FIGURE 48.SPINAL IMPLANTS AND DEVICES MARKET FOR CELL BASED MATRIX ($MILLION), 2019-2027
  • FIGURE 49.COMPARATIVE SHARE ANALYSIS OF OPEN SPINE SURGERY, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 50.COMPARATIVE SHARE ANALYSIS OF MINIMALLY INVASIVE SPINE SURGERY, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 51.POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
  • FIGURE 52.ALPHATEC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 53.B. BRAUN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 54.B. BRAUN: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 55.B. BRAUN: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 56.J&J: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 57.J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 58.J&J: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 59.GLOBUS MEDICAL: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 60.GLOBUS MEDICAL: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 61.GLOBUS MEDICAL: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 62.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 63.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 64.MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 65.NUVASIVE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 66.NUVASIVE: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 67.ORTHOFIX: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 68.ORTHOFIX: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 69.ORTHOFIX: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 70.STRYKER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 71.STRYKER: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 72.ZIMMER BIOMET: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 73.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 74.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2019 (%)